Get Demo
1 min read

Use of Appropriate Scoring System for Immunohistochemistry (IHC) for HER2/neu Testing for Invasive Breast Cancer

Percentage of final pathology reports for immunohistochemistry (IHC) for HER2/neu testing for invasive breast cancer that include interpretation of the results in accordance with the 2018, 2023 or later ASCO-CAP Guideline Update.
admin_macra

admin_macra

Administrator

Published

May 22, 2026

Reading Time

1 min read

Percentage of final pathology reports for immunohistochemistry (IHC) for HER2/neu testing for invasive breast cancer that include interpretation of the results in accordance with the 2018, 2023 or later ASCO-CAP Guideline Update.

  • TRENDING ANALYTICS

Engineering

Optimizing Vector Databases for RAG Applications

Engineering

The ROI of Migrating to a Semantic Layer

Engineering

The ROI of Migrating to a Semantic Layer

READING PROGRESS

SHARE ARTICLE